Literature DB >> 11576962

Screening for cancer in venous thromboembolic disease.

T Fennerty.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11576962      PMCID： PMC1121269          DOI： 10.1136/bmj.323.7315.704

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism.

Authors:  H T Sørensen; L Mellemkjaer; F H Steffensen; J H Olsen; G L Nielsen
Journal:  N Engl J Med       Date:  1998-04-23       Impact factor: 91.245

2.  Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis.

Authors:  J Cornuz; S D Pearson; M A Creager; E F Cook; L Goldman
Journal:  Ann Intern Med       Date:  1996-11-15       Impact factor: 25.391

3.  Prognosis of cancers associated with venous thromboembolism.

Authors:  H T Sørensen; L Mellemkjaer; J H Olsen; J A Baron
Journal:  N Engl J Med       Date:  2000-12-21       Impact factor: 91.245

4.  Deep-vein thrombosis and the incidence of subsequent symptomatic cancer.

Authors:  P Prandoni; A W Lensing; H R Büller; A Cogo; M H Prins; A M Cattelan; S Cuppini; F Noventa; J W ten Cate
Journal:  N Engl J Med       Date:  1992-10-15       Impact factor: 91.245

5.  Deep venous thrombosis and occult malignancy: an epidemiological study.

Authors:  M Nordström; B Lindblad; H Anderson; D Bergqvist; T Kjellström
Journal:  BMJ       Date:  1994-04-02

6.  Occult cancer in patients with deep venous thrombosis. A systematic approach.

Authors:  M Monreal; E Lafoz; A Casals; L Inaraja; E Montserrat; J M Callejas; A Martorell
Journal:  Cancer       Date:  1991-01-15       Impact factor: 6.860

7.  Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis.

Authors:  R J Hettiarachchi; J Lok; M H Prins; H R Büller; P Prandoni
Journal:  Cancer       Date:  1998-07-01       Impact factor: 6.860

8.  The incidence of occult cancer in patients with deep venous thrombosis: a prospective study.

Authors:  E A Bastounis; A J Karayiannakis; G G Makri; D Alexiou; E L Papalambros
Journal:  J Intern Med       Date:  1996-02       Impact factor: 8.989

9.  Venous thromboembolism and cancer.

Authors:  J A Baron; G Gridley; E Weiderpass; O Nyrén; M Linet
Journal:  Lancet       Date:  1998-04-11       Impact factor: 79.321
  9 in total
  5 in total

Review 1.  Venous thromboembolic disease and cancer.

Authors:  A Fennerty
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

2.  Stroke as a first manifestation of ovarian cancer.

Authors:  Andreas Borowski; Ali Ghodsizad; Emmeran Gams
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

3.  Deep vein thrombosis in primary care: possible malignancy?

Authors:  Ruud Oudega; Karel G M Moons; H Karel Nieuwenhuis; Fred L van Nierop; Arno W Hoes
Journal:  Br J Gen Pract       Date:  2006-09       Impact factor: 5.386

4.  Prognosis of patients with suspected pulmonary embolism in Buenos Aires: a prospective cohort study.

Authors:  Fernando Javier Vazquez; María Lourdes Posadas-Martínez; Fernán González Bernaldo de Quirós; Diego Hernan Giunta
Journal:  BMC Pulm Med       Date:  2014-12-15       Impact factor: 3.317

5.  Predictive score for estimating cancer after venous thromboembolism: a cohort study.

Authors:  Bruno L Ferreyro; Federico Angriman; Diego Giunta; María Lourdes Posadas-Martínez; Fernando Vazquez; Fernán Gonzalez Bernaldo De Quirós; Andre C K B Amaral; Damon C Scales
Journal:  BMC Cancer       Date:  2013-07-22       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.